[{"NetIncomeLoss_1_Q2_USD":-26068000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":-9521000.0,"LiabilitiesFairValueDisclosure_0_Q2_USD":68600000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":108644000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":108644000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":107353000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":1399000.0,"LeaseIncentiveReceivable_0_Q2_USD":1983000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":-4634000.0,"BusinessCombinationContingentConsiderationLiability_0_Q2_USD":68600000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":44379000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q2_USD":5015000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":44763843.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":43943370.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":19.2,"ProvisionForDoubtfulAccounts_2_Q2_USD":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":3249000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":9000.0,"CostMethodInvestments_0_Q2_USD":15000000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":1590000.0,"ConvertibleDebtNoncurrent_0_Q2_USD":210009000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":11474000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":5760000.0,"SaleOfStockPricePerShare_0_Q2_USD":15.5,"InventoryValuationReserves_0_Q2_USD":3600000.0,"AccruedSalariesCurrent_0_Q2_USD":10011000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":17110450000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":16878538000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":1494000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":2864000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":34971000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":68110000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":36743000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-496000.0,"OperatingLeaseExpense_1_Q2_USD":200000.0,"OperatingLeaseExpense_2_Q2_USD":600000.0,"AssetsCurrent_0_Q2_USD":505562000.0,"OperatingLeaseLiability_0_Q2_USD":8268000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":1543000.0,"Liabilities_0_Q2_USD":360049000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":6889000.0,"CommonStockValue_0_Q2_USD":5000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":65000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-18911000.0,"AccountsReceivableNetCurrent_0_Q2_USD":14077000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":426000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":235000.0,"ProceedsFromStockPlans_2_Q2_USD":1098000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":87084000.0,"AssetsFairValueDisclosure_0_Q2_USD":457376000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":729000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-33000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":153300000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":99072000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q2_USD":9000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":13372000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":30790000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":3146000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q2_USD":0.0,"StockGrantedDuringPeriodValueSharebasedCompensationGross_2_Q2_USD":431000.0,"StockGrantedDuringPeriodValueSharebasedCompensationGross_1_Q2_USD":371000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":237170000.0,"OtherAssetsNoncurrent_0_Q2_USD":13895000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":5285000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":10459000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-23169000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-24587000.0,"IncreaseDecreaseInInventories_2_Q2_USD":875000.0,"NumberOfBusinessesAcquired_2_Q2_business":2.0,"CostsAndExpenses_1_Q2_USD":71541000.0,"CostsAndExpenses_2_Q2_USD":134375000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":-8674000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_2_Q2_USD":6101000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q2_USD":9000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":103022000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":222000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":11507000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-16407000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":758945000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":3146000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":729000.0,"ForeignCurrencyTransactionGainLossRealized_2_Q2_USD":-56000.0,"InterestIncomeExpenseNet_2_Q2_USD":3291000.0,"TemporaryEquityForeignCurrencyTranslationAdjustments_1_Q2_USD":-247000.0,"TemporaryEquityForeignCurrencyTranslationAdjustments_2_Q2_USD":-56000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-26003000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-44171000.0,"Goodwill_0_Q2_USD":936000.0,"DebtInstrumentRepurchaseAmount_0_Q2_USD":23400000.0,"InterestIncomeExpenseNet_1_Q2_USD":1316000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":1619000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-3979000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":174734000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-441704000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":5300000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":5147000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":-196000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-337000.0,"CommonStockSharesOutstanding_0_Q2_shares":50902874.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-35608000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":3037000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":960000.0,"NetIncomeLoss_2_Q2_USD":-25260000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2930000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q2_USD":5015000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":155371000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":1487000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":1291000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":8532000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":2508000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":431000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":7714000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":237170000.0,"NonoperatingIncomeExpense_1_Q2_USD":-2892000.0,"NonoperatingIncomeExpense_2_Q2_USD":-5995000.0,"SaleOfStockNumberOfSharesIssuedInTransaction_0_Q2_shares":7500000.0,"AccountsPayableCurrent_0_Q2_USD":10198000.0,"LiabilitiesCurrent_0_Q2_USD":69933000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":218596000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":518000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q2_USD":0.0,"StockholdersEquity_0_Q2_USD":318645000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":48430000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":96199000.0,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":1637000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":3121000.0,"ConvertibleDebtFairValueDisclosures_0_Q2_USD":225900000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_0_Q2_USD":108600000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":108644000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OperatingLeaseRightOfUseAsset_0_Q2_USD":6912000.0,"ShareBasedCompensation_2_Q2_USD":11474000.0,"Assets_0_Q2_USD":678694000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":220206000.0,"CommonStockSharesIssued_0_Q2_shares":50902874.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":153146000.0,"ForeignCurrencyTransactionGainLossRealized_1_Q2_USD":-247000.0,"OperatingIncomeLoss_2_Q2_USD":-38176000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":61038000.0,"OperatingIncomeLoss_1_Q2_USD":-23111000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":133122000.0,"OtherLiabilitiesCurrent_0_Q2_USD":7356000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":19507000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.58,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.57,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1379000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q2_USD":0.0,"ImpairmentOfIntangibleAssetsFinitelived_1_Q2_USD":0.0,"ImpairmentOfIntangibleAssetsFinitelived_2_Q2_USD":0.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":5954000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":11864000.0,"PreferredStockSharesAuthorized_0_Q2_shares":20000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":678694000.0,"PreferredStockValue_0_Q2_USD":0.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":254443000.0,"IncomeTaxReceivable_0_Q2_USD":20109000.0,"IncreaseDecreaseInIncomeTaxesReceivable_2_Q2_USD":18714000.0,"InventoryNet_0_Q2_USD":6286000.0,"DebtSecuritiesAvailableForSaleAmortizedCostCurrent_0_Q2_USD":218596000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1207000.0,"Ticker":"TVTX","CIK":"1438533","name":"RETROPHIN, INC.","OfficialName":"Travere Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1905907401.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200731"}]